Recursion Pharmaceuticals, Inc.

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Mubadala Investment Co PJSC

(Last)

(First)

(Middle)

P.O. BOX 45005

(Street)

ABU DHABI

00000

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2021

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	04/20/2021		C		3,578,653	A	⁽⁶⁾	3,578,653	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Class A Common Stock	04/20/2021		C		2,738,824	A	⁽⁷⁾	6,317,477	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Class A Common Stock	04/20/2021		C		745,392	A	⁽⁸⁾	7,062,869	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Class A Common Stock	04/16/2021		P		2,777,777	A	$18	2,777,777	I	See Explanation of Responses⁽²⁾⁽³⁾⁽⁴⁾⁽⁵⁾
Class A Common Stock	04/20/2021		C		5,963,140	A	⁽⁸⁾	8,740,917	I	See Explanation of Responses⁽²⁾⁽⁴⁾⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series B Convertible Preferred Stock	⁽⁶⁾	04/20/2021		C			3,578,653	⁽⁶⁾	⁽⁶⁾	Class A Common Stock	3,578,653	⁽⁶⁾	0	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Series C Convertible Preferred Stock	⁽⁷⁾	04/20/2021		C			2,307,475	⁽⁷⁾	⁽⁷⁾	Class A Common Stock	2,738,824	⁽⁷⁾	0	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Series D Convertible Preferred Stock	⁽⁸⁾	04/20/2021		C			745,392	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	745,392	⁽⁸⁾	0	I	See Explanation of Responses⁽¹⁾⁽⁴⁾⁽⁵⁾
Series D Convertible Preferred Stock	⁽⁸⁾	04/20/2021		C			5,963,140	⁽⁸⁾	⁽⁸⁾	Class A Common Stock	5,963,140	⁽⁸⁾	0	I	See Explanation of Responses⁽²⁾⁽⁴⁾⁽⁵⁾

1. Name and Address of Reporting Person^*

Mubadala Investment Co PJSC

(Last)

(First)

(Middle)

P.O. BOX 45005

(Street)

ABU DHABI

00000

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Mamoura Diversified Global Holding PJSC

(Last)

(First)

(Middle)

P. O. BOX 45005

(Street)

ABU DHABI

UAE

(City)

(State)

(Zip)

Explanation of Responses:

1. MDC Capital Partners (Ventures) GP, LP is the general partner of MDC Capital Partners (Ventures), LP, which directly holds 7,062,869 shares of Class A Common Stock ("Class A Shares"). MDC Capital Partners (Ventures) GP, LP has created an investment committee comprised of four individual members, which has the authority, by affirmative majority consent, to approve all investment and divestment decisions made with respect to MDC Capital Partners (Ventures), LP. Each of the members of the investment committee expressly disclaims beneficial ownership of the shares held by MDC Capital Partners (Ventures), LP.

2. Consists of (i) 2,777,777 shares held of record by Fifteenth Investment Company LLC and (ii) 5,963,140 shares held of record by Thirty Fifth Investment Company LLC. Both Fifteenth Investment Company LLC and Thirty Fifth Investment Company LLC are wholly owned subsidiaries of Mamoura Diversified Global Holdings PJSC, which is wholly owned by Mubadala Investment Company PJSC, which is wholly owned by the Government of Abu Dhabi.

3. On April 16, 2021, Fifteenth Investment Company LLC acquired 2,777,777 Class A Shares at a price of $18 per share in connection with Recursion Pharmaceutical, Inc.'s (the "Issuer") initial public offering.

4. Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.

5. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

6. The shares of Series B Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

7. The shares of Series C Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1.1869 basis automatically upon the closing of the initial public offering of the Issuer.

8. The shares of Series D Convertible Preferred Stock were automatically converted into Class A Shares on a 1-for-1 basis automatically upon the closing of the initial public offering of the Issuer.

Remarks:

9. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.

	/s/ Samer Halawa, Chief Legal Officer, Mubadala Investment Company PJSC (9)	04/20/2021
	/s/ Samer Halawa, Chief Legal Officer, Mamoura Diversified Global Holdings PJSC (9)	04/20/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.